Immuna

Immunis receives FDA clearance for Phase II sarcopenic obesity therapy trial
Clinical Trials Arena
Wed, 09/11/24 - 11:22 am
Immunis
FDA
clinical trials
Immuna
obesity
sarcopenic obesity